Viking Therapeutics Inc
LSE:0VQA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Viking Therapeutics Inc
LSE:0VQA
|
US |
|
K
|
Koninklijke Philips NV
XHAM:PHI1
|
NL |
|
S
|
Snap-On Inc
F:SPU
|
US |
|
East Japan Railway Co
TSE:9020
|
JP |
|
Pebblebrook Hotel Trust
NYSE:PEB
|
US |
|
Star Bulk Carriers Corp
NASDAQ:SBLK
|
GR |
|
T
|
Target Corp
DUS:DYH
|
US |
|
M
|
Mitsui Chemicals Inc
XMUN:MSI
|
JP |
|
Curtis Banks Group PLC
LSE:CBP
|
UK |
|
E
|
El Pollo Loco Holdings Inc
F:EP6
|
US |
Wall St Price Targets
0VQA Price Targets Summary
Viking Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
0VQA is 91.48 USD with a low forecast of 33.04 USD and a high forecast of 126.27 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0VQA's stock price target?
Price Target
91.48
USD
According to Wall Street analysts, the average 1-year price target for
0VQA is 91.48 USD with a low forecast of 33.04 USD and a high forecast of 126.27 USD.